Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous vs Intravenous Vancomycin in Diabetic Foot Amputation
NCT07338773Phase 4Completed
- Sponsor
- Başakşehir Çam & Sakura City Hospital
- Start
- Aug 2025
- Primary completion
- Jun 2026
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in diabetic foot infection (DFI), sponsored by Başakşehir Çam & Sakura City Hospital. Started Aug 2025; status: completed.
02
Drugs
vancomycin
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT07338773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07338773.